Skip to main content Skip to section navigation Skip to footer
Stock Information
chevron_left Back to CastleBiosciences.com
Castle Biosciences, Inc. IR Home
  • Overview
  • News & Events keyboard_arrow_down
    • Press Releases
    • IR Events
    • Presentations
    • In The Media
    • Annual Meeting
    • Email Alerts
  • Company Info keyboard_arrow_down
    • Company Profile
    • Executive Team
    • Annual Reports & Proxy
    • Contacts
    • FAQ
  • Financial Info keyboard_arrow_down
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data keyboard_arrow_down
    • Quote & Chart
    • Historical Data
    • Analyst Coverage
  • SEC Filings keyboard_arrow_down
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance keyboard_arrow_down
    • Governance Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Corporate Responsibility
  • Resources keyboard_arrow_down
    • Scientific Evidence
  • Stock Information
  • chevron_leftBack to CastleBiosciences.com

In The Media

News & Events

  • Press Releases
  • IR Events
  • Presentations
  • In The Media
  • Annual Meeting
  • Email Alerts
Feb 20, 2026
Dermatology Times: JAAD Study Validates 487-GEP to Guide JAK Inhibitor Selection in Moderate to Severe AD
Feb 20, 2026
Cure: Combining Genetic Tests Offers Superior Risk Prediction in Uveal Melanoma
Feb 20, 2026
Clinical Lab Products: New Gene Expression Test Helps Guide Atopic Dermatitis Treatment Decisions
Feb 19, 2026
JCAD Podcast: James Del Rosso, DO, and David Cotter, MD, PhD: The Use of Gene-Expression Profile Testing for Effective Atopic Dermatitis Treatment
Feb 12, 2026
Dermatology Times: Advancing Equity, Precision, and Awareness in Dermatology
Feb 10, 2026
Dermatology Times: Precision Medicine Arrives in Atopic Dermatitis: Guiding Systemic Treatment Decisions Through Gene Expression Profiling
Feb 1, 2026
The CEO Magazine: Derek Maetzold is Building Precision Diagnostics and Reshaping Personalized Care for Patients
Jan 31, 2026
Hematology & Oncology: The Evolution of Treatment for Uveal Melanoma
Jan 26, 2026
The Dermatology Digest: Castle Biosciences’ 23-GEP Test Performs Well in Pediatric Populations
Jan 19, 2026
Practical Dermatology: Dr. Darrell Rigel Highlights Urgent Skin Cancer Trends at Winter Clinical 2026
rss_feed RSS
  • Previous Pagearrow_back
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • …
  • Page 26
  • Next Pagearrow_forward
  • emailEmail Alerts
  • location_cityCompany Profile
  • contact_pageContacts
  • rss_feedRSS News Feed
©2026 Castle Biosciences, Inc. All Rights Reserved.
  • Privacy Policy
  • Disclaimer
  • Sitemap
  • Accessibility Statement

Market Data copyright © 2026 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.